longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

DRTG: The transfer of 13% equity in Tianjin Shike has been completed

Zhitong
Dec 31, 2024 at 08:17 AM

DRTG announced that the transaction of transferring its 13% equity stake in China-U.S. Tianjin Sihua Pharmaceutical Co., Ltd. to Helion Limited has been completed. After the transaction, the company's equity stake in Tianjin Sihua has changed from 25% to 12%, and it remains a shareholder of Tianjin Sihua

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Sep 8, 2026 at 12:14 PMAI-era DCI: Beyond the chip, compete as a network. Is there a China play?
DRTG

DRTG

600329.SH

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI